Facebook
X
LinkedIn
ForwardEmerging Toxicology Trends from the Iowa Poison Control Center
| Registration |
|---|
If you have questions, please email Kristina Seier. |
Learning Objectives
- Describe the core functions of the Iowa Poison Control Centers and how physicians can effectively utilize these services in the evaluation and management of patients with suspected toxic exposures.
- Identify common clinical presentations, risks, and management considerations associated with newer and emerging substances of abuse, including kratom and synthetic cannabinoids
- Apply recommendations to clinical decision-making for patients with suspected toxic exposures.
Speaker
Joshua Trebach, MD, FAACT
Medical Toxicologist, Emergency Medicine Physician, Iowa Poison Control Center
Dr. Trebach is a medical toxicologist and emergency physician at the University of Iowa Hospitals and Clinics (UIHC). He is also a Clinical Assistant Professor of Emergency Medicine at UIHC and is the Associate Medical Director at the Iowa Poison Control Center. Dr. Trebach received his medical degree from the Johns Hopkins University School of Medicine and completed his residency in emergency medicine at Johns Hopkins Hospital. Dr. Trebach completed his medical toxicology fellowship training at New York University/New York City Poison Control Center. Dr. Trebach’s interests include medical education, public health, clinical research, disaster preparedness, plants/mushrooms, and all things toxicology!
Accreditation Statements
- MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University Medicine and Health Sciences
(DMU) and the Iowa Medical Society. DMU is accredited by IMS to provide continuing medical education for physicians. DMU designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. - DO: Des Moines University Medicine and Health Sciences (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity for a maximum of 1.0 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- Other Healthcare Professionals: This activity is designated for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.
 |  |
Educational Grants
No ineligible company provided financial support for this continuing education activity.
Disclosures
The speaker(s) will disclose if any pharmaceuticals, medical procedures, or devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The activity director is responsible for determining educational content and selecting speakers.
Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with ineligible companies to disclose.
- Ryan Roberts - Planning Committee Member
- Kristina Seier, LMSW - Activity Director and Planning Committee Member
- Joshua Trebach, MD, FAACT - Speaker
Disclaimer
The information provided in this activity is for continuing education purposes only. It is not a substitute for a healthcare provider's independent medical judgment regarding diagnostic and treatment options for a specific patient's medical condition.
Available Credit
- 1.00 AMA PRA Category 1 Credits™
- 1.00 AOA Category 2A
- 1.00 CE Contact Hour(s)